Thurston, Springer, Miller, Herd & Titak, Inc. Neogenomics Inc Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $558 Million
- Q1 2025
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 300 shares of NEO stock, worth $2,352. This represents 0.0% of its overall portfolio holdings.
Number of Shares
300
Previous 300
-0.0%
Holding current value
$2,352
Previous $4,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NEO
# of Institutions
275Shares Held
121MCall Options Held
751KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$154 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$112 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.53MShares$51.2 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.17MShares$48.3 Million0.05% of portfolio
-
State Street Corp Boston, MA5.2MShares$40.8 Million0.0% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $986M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...